Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction
Speaker:
Associate Professor M. Dzeshka (Grodno, BY)
Outcomes of heart failure with reduced ejection fraction (HFrEF) status post implantable cardioverter-defibrillator (ICD) presenting with HFrEF exacerbation with verses without atrial fibrillation(AF)